Healthcare and medical science are constantly evolving disciplines, changing with the times and advancing with technology. Given the rise in digitalisation, Ramsay Sime Darby Health Care (RSDH) is harnessing its benefits; this time by investing in a new technology breakthrough to foster more seamless diabetes care, while optimising productivity at all its hospitals.
Aiming to provide a more personalized ecosystem of care that ensures convenience, efficiency, and a seamless patient experience, RSDH recently entered into an agreement with leading multinational healthcare and biotech company, Roche Diagnostics (M) Sdn Bhd (Roche Diabetes Care), to adopt the RocheDiabetes Care Platform (RDCP) across its hospitals in Malaysia.
According to the International Diabetes Federation’s (IDF) Malaysia Diabetes Report 2000 -2045, diabetes is expected to affect over 6 million Malaysian adults aged 20 and above by 2024. RSDH’s timely move to adopt RDCP will allow for more shared decision-making in order to improve management of the disease and mitigate secondary health complications.
Peter Hong, Group Chief Executive Officer, RSDH, said, “Emerging technologies are reshaping healthcare in multiple ways and the pandemic has served as a catalyst for the greater adoption of telehealth services around the globe. This has radically changed the way medical practitioners and healthcare providers care for patients. By offering user-friendly digital solutions, we are revolutionising the treatment and management of diabetes while accelerating efficiency and narrowing the digital gap in healthcare practice in Malaysia.”
RDCP organises and distills relevant diabetes patient data into structured visualisations that support informed and personalised treatment decisions. With visibility and access to a broad spectrum of individual patient data, healthcare professionals can derive insights for therapy intervention and treatment solutions with their patients.
“We are creating patient-centred value with our partners by fostering sustainable healthcare structures through an integrated Personalised Diabetes Management (iPDM) approach,” said Bryan Koh, Cluster Head of Asia Pacific Mature Markets at Roche Diabetes Care. “By expanding access to individualised and aggregated patient data from various connected diabetes management devices and digital solutions, we enable healthcare professionals to combine data analytics with medical expertise to help people with diabetes take charge of their health goals for true relief.”
The RocheDiabetes Care Platform supports over 150 diabetes management devices and solutions from different brands. By connecting either via a specialised app, patient portal, or uploading data at the healthcare facility, diabetes-relevant patient data is collected in a secure and compliant manner from devices such as blood glucose meters, insulin pumps, and other systems for insightful consultations. The system analyses the patient’s diabetes data using charts, graphs, and statistics that allow care team members to monitor the impact of current glucose management and lifestyle decisions on blood glucose levels.
Subang Jaya Medical Centre, ParkCity Medical Centre and Bukit Tinggi Medical Centre have successfully implemented RDCP, while the platform is expected to go live at Ara Damansara Medical Centre in April 2023.